Currently out of the existing stock ratings of Young Li, 8 are a BUY (42.11%), 11 are a HOLD (57.89%).
Analyst Young Li, currently employed at JEFFERIES, has had 41.67% of price targets met with an average potential upside of 13.6%, reached in 42 days on average. Previously, Young Li worked at UBS.
Young Li has documented 38 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on STAA, STAAR Surgical Company at 22-Sep-2026.
Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for CNMD (CONMED) on 10/11/2022. The price target of $85 was fulfilled within 31 days with a profit of $10.04 (13.39%), with a performance score of 4.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$7.6 (56.72%)
$16
3 months 17 days ago
(30-Jul-2026)
2/2 (100%)
$2.93 (16.21%)
134
Buy Since 03-Nov-2023
$17
$3.6 (26.87%)
$16
8 months 20 days ago
(27-Feb-2026)
17/22 (77.27%)
$2.64 (18.38%)
172
Hold Since 14-Oct-2022
$24
$23
2 years 5 months 18 days ago
(29-May-2024)
5/5 (100%)
$-1.64 (-6.40%)
129
Buy Since 09-Aug-2023
$32
3 years 3 months 7 days ago
(09-Aug-2023)
1/2 (50%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$55
4 years 8 months 7 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
Which stock is Young Li most bullish on?
Which stock is Young Li most reserved on?
What Year was the first public recommendation made by Young Li?